Key Takeaways
- Pharmacy prescription revenue drives Bankable approval — no green card required
- Fund inventory, POS systems, and working capital for OPT pharmacy owners
- Independent and specialty pharmacy operations both qualify
- 48-hour decisions for pharmacies with $25K+ monthly revenue
Independent pharmacy owners on F-1 OPT — typically pharmacists who completed their PharmD in the US and entered OPT — are running prescription dispensing operations with consistent, documentable revenue from insurance reimbursements and cash prescriptions. The independent pharmacy sector is experiencing a renaissance as communities seek personalized pharmaceutical care that chain pharmacies can't provide.
Pharmacy Capital Uses
- Drug inventory financing: stock controlled substances, specialty medications, and OTC products
- POS and pharmacy management software upgrades
- Compounding pharmacy equipment: sterile compounding hoods and equipment
- Working capital for insurance reimbursement lag (PBM payments: 14-30 days)
- Second pharmacy location acquisition or buildout
Frequently Asked Questions
Yes. Since March 2026, SBA loans require 100% US citizen or national ownership. Bankable is non-SBA — F-1 OPT founders qualify based entirely on business revenue.
No. Bankable funds US-registered business entities based on revenue. Immigration status is not evaluated.
Your business entity continues operating and servicing funding. The loan is with the business, not the individual.
Yes. A licensed pharmacist on F-1 OPT can own and operate an independent pharmacy. State pharmacy board requirements for pharmacy ownership vary — some require a licensed pharmacist owner; others allow non-pharmacist ownership.
$25,000+ in monthly prescription and OTC revenue with 6+ months of operating history.
Yes. Specialty pharmacy operations with specialty drug dispensing revenue often qualify for higher funding amounts due to higher average prescription values.
Yes. Drug inventory financing against documented purchase orders and insurance contracts is available for independent pharmacies.
The 14-30 day PBM reimbursement cycle is built into our cash flow analysis. Working capital to bridge the payment gap is a primary use case for independent pharmacies.